IRVINE, Calif.--(BUSINESS WIRE)--Jan. 19, 2016--
Masimo
(NASDAQ: MASI) announced today that a member of its Board of Directors,
Chairman of its Scientific Advisory Board, and its Chief Science
Officer, Steven Barker, Ph.D., M.D., was honored with the 2016 J.S.
Gravenstein Award recognizing lifetime achievement at this month’s
Society for Technology in Anesthesia (STA) Annual Meeting in Palm Beach,
Florida.
“We selected Dr. Barker as the recipient of the Gravenstein Award
because of his years of innovation, instruction and service,” said Dr.
Joseph Orr, President of the STA. “Dr. Barker is a rare combination of
training in the physical sciences (Ph.D. in aerospace engineering) and
in medicine. Over the years, he has been able to apply his training,
research and talent to study and improve medical monitoring devices.
Through his collaboration with Masimo, Dr. Barker’s work has improved
technology available for clinical anesthesia practice.”
The STA was founded in 1988 and is an international organization of
physicians, engineers, students and others with an interest in
anesthesia-related technologies. The organization also publishes the
journal Anesthesia & Analgesia. Each year, the STA bestows
the J.S. Gravenstein Award for lifetime achievement in the area of
technology in anesthesia. The J.S. Gravenstein Award is named for J.S.
“Nik” Gravenstein (1925-2009), a founding member and former president of
the STA. For over thirty years, Dr. Gravenstein was a driving force in
advancing anesthesia technology, patient simulation and anesthesia
patient safety.
“This is a great honor and we are very proud of Steve,” said Joe Kiani,
Founder and CEO of Masimo. “He has always been at the forefront of
technology development and research in every area of anesthesia, but
what sets Steve apart is his commitment to the truth and integrity. His
work has contributed to improving quality of care and patient safety
around the world.”
Steven J. Barker, Ph.D., M.D., received his Ph.D. in Aeronautical
Engineering from the California Institute of Technology in 1972, and his
M.D. from the University of Miami in 1981. He has reached the rank of
tenured professor in both engineering (University of California at Los
Angeles) and anesthesiology (University of California at Irvine,
University of Arizona). He chaired the Department of Anesthesiology at
UC Irvine from 1990 to 1995, and then at the University of Arizona from
1995 to 2013. He has published over 150 scholarly works, including 15
textbook chapters. Dr. Barker has served as president of the national
organization of anesthesiology department chairs (AAPD) and of the
Society for Technology in Anesthesia (STA), senior oral examiner for the
American Board of Anesthesiology, and Section Editor for Technology for
the journal Anesthesia & Analgesia. During his 18-year tenure
as anesthesiology chair at the University of Arizona, Dr. Barker was
active in a number of governance roles outside of his department. He
also served seven years as the American Society of Anesthesiologists
(ASA) Director for Academic Anesthesiology, representing all university
anesthesiology departments for ASA. Since 2005, Dr. Barker has been a
member of Masimo’s Board of Directors and Chairman of Masimo’s
Scientific Advisory Board. In 2015, Dr. Barker also took on the role of
Chief Science Officer of Masimo.
@MasimoInnovates
| #Masimo
About Masimo
Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive
monitoring technologies. Our mission is to improve patient outcomes and
reduce the cost of care by taking noninvasive monitoring to new sites
and applications. In 1995, the company debuted Masimo SET®
Measure-through Motion and Low Perfusion™ pulse oximetry, which has been
shown in multiple studies to significantly reduce false alarms and
accurately monitor for true alarms. The benefits of Masimo SET® have
been proven in more than 100 independent and objective studies and it is
estimated to be used on more than 100 million patients in leading
hospitals and other healthcare settings around the world. In 2005,
Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing
noninvasive and continuous monitoring of blood constituents that
previously could only be measured invasively, including total hemoglobin
(SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®),
methemoglobin (SpMet®), and more recently, Pleth Variability Index
(PVI®) and Oxygen Reserve Index (ORI™), in addition to SpO2, pulse rate,
and perfusion index (PI). In 2014, Masimo introduced Root®, an intuitive
open architecture patient monitoring and connectivity platform designed
to speed the pace of innovation and reduce the cost of care. Masimo is
also taking an active leadership role in mHealth with products such as
the Radius-7™ wearable patient monitor and the MightySat™ fingertip
pulse oximeter. Additional information about Masimo and its products may
be found at www.masimo.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160119005418/en/
Source: Masimo
Masimo
Irene Paigah, 858-859-7001
irenep@masimo.com